Related Experiment Videos
Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells
Yoshihiro Inami1, Satoshi Waguri, Ayako Sakamoto
1Protein Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo 156-8501, Japan.
Abstract:
Suppression of autophagy is always accompanied by marked accumulation of p62, a selective autophagy substrate. Because p62 interacts with the Nrf2-binding site on Keap1, which is a Cullin 3-based ubiquitin ligase adapter protein, autophagy deficiency causes competitive inhibition of the Nrf2-Keap1 interaction, resulting in stabilization of Nrf2 followed by transcriptional activation of Nrf2 target genes. Herein, we show that liver-specific autophagy-deficient mice harbor adenomas linked to both the formation of p62- and Keap1-positive cellular aggregates and induction of Nrf2 targets. Importantly, similar aggregates were identified in more than 25% of human hepatocellular carcinomas (HCC), and induction of Nrf2 target genes was recognized in most of these tumors. Gene targeting of p62 in an HCC cell line markedly abrogates the anchorage-independent growth, whereas forced expression of p62, but not a Keap1 interaction-defective mutant, resulted in recovery of the growth defect. These results indicate the involvement of persistent activation of Nrf2 through the accumulation of p62 in hepatoma development.
Insights
Autophagy suppression leads to p62 accumulation, activating Nrf2 and promoting liver cancer (hepatocellular carcinoma). Targeting p62 inhibits tumor growth, highlighting its role in hepatoma development.
Area of Science:
- Cell Biology
- Oncology
- Molecular Biology
Background:
- Autophagy suppression causes p62 accumulation, which competitively inhibits the Nrf2-Keap1 interaction.
- This inhibition stabilizes Nrf2, leading to the transcriptional activation of Nrf2 target genes.
Purpose of the Study:
- To investigate the role of p62 accumulation and Nrf2 activation in liver cancer development.
- To determine the therapeutic potential of targeting p62 in hepatocellular carcinoma (HCC).
Main Methods:
- Utilized liver-specific autophagy-deficient mice to study hepatoma development.
- Analyzed human HCC tissues for p62 and Keap1-positive aggregates and Nrf2 target gene induction.
- Employed gene targeting and forced expression of p62 in an HCC cell line.
Main Results:
- Autophagy-deficient mice developed adenomas with p62/Keap1 aggregates and Nrf2 target gene induction.
- Similar aggregates and Nrf2 activation were found in over 25% of human HCCs.
- p62 gene targeting abrogated HCC cell growth, while p62 overexpression restored it.
Conclusions:
- Persistent Nrf2 activation due to p62 accumulation is implicated in hepatoma development.
- p62 is a potential therapeutic target for hepatocellular carcinoma.
Related Concept Videos
Abnormal Proliferation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis II: Pathophysiology
Regulation of Nuclear Protein Sorting
MAPK Signaling Cascades